Gold, Ralf

Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution

Masuda, T., Sankowski, R., Staszewski, O., Böttcher, C., Amann, L., Sagar, Scheiwe, C., Nessler, S., Kunz, P., van Loo, G., et al. (2019) · Nature

Neuroinflammation and Neurodegeneration MechanismsSingle-cell and spatial transcriptomics

Cited by 1,310

Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway

Linker, R. A., Lee, D.-H., Ryan, S., van Dam, A. M., Conrad, R., Bista, P., Zeng, W., Hronowsky, X., Buko, A., Chollate, S., et al. (2011) · Brain

Multiple Sclerosis Research StudiesGenomics, phytochemicals, and oxidative stress

Cited by 1,155

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research

Gold, R. (2006) · Brain

Multiple Sclerosis Research StudiesT-cell and B-cell Immunology

Cited by 1,017

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet

Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling

Cited by 942

Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine

Haghikia, A., Jörg, S., Duscha, A., Berg, J., Manzel, A., Waschbisch, A., Hammer, A., Lee, D.-H., May, C., Wilck, N., et al. (2015) · Immunity

T-cell and B-cell ImmunologyMultiple Sclerosis Research Studies

Cited by 927

Sex and gender issues in multiple sclerosis

Harbo, H. F., Gold, R., & Tintoré, M. (2013) · Therapeutic Advances in Neurological Disorders

Multiple Sclerosis Research StudiesSex and Gender in Healthcare

Cited by 529

Progressive multiple sclerosis: from pathophysiology to therapeutic strategies

Faissner, S., Plemel, J. R., Gold, R., & Yong, V. W. (2019) · Nature Reviews Drug Discovery

Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms

Cited by 459

Animal models for autoimmune demyelinating disorders of the nervous system

Gold, R., Hartung, H.-P., & Toyka, K. V. (2000) · Molecular Medicine Today

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 292

Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis.

Schmidt, J., Metselaar, J. M., Wauben, M. H. M., Toyka, K. V., Storm, G., & Gold, R. (2003) · Brain

Multiple Sclerosis Research StudiesNanoparticle-Based Drug Delivery

Cited by 204

Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis

Beyersdorf, N., Gaupp, S., Balbach, K., Schmidt, J., Toyka, K. V., Lin, C.-H., Hanke, T., Hünig, T., Kerkau, T., & Gold, R. (2005) · The Journal of Experimental Medicine

T-cell and B-cell ImmunologyMultiple Sclerosis Research Studies

Cited by 203

Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine

Haghikia, A., Jörg, S., Duscha, A., Berg, J., Manzel, A., Waschbisch, A., Hammer, A., Lee, D.-H., May, C., Wilck, N., et al. (2016) · Immunity

Multiple Sclerosis Research StudiesT-cell and B-cell Immunology

Cited by 122

Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis

Abrahamyan, S., Eberspächer, B., Hoshi, M.-M., Aly, L., Luessi, F., Groppa, S., Klotz, L., Meuth, S. G., Schroeder, C., Grüter, T., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry

Multiple Sclerosis Research StudiesViral-associated cancers and disorders

Cited by 119

Rapid Regulatory T-Cell Response Prevents Cytokine Storm in CD28 Superagonist Treated Mice

Gogishvili, T., Langenhorst, D., Lühder, F., Elias, F., Elflein, K., Dennehy, K. M., Gold, R., & Hünig, T. (2009) · PLoS ONE

T-cell and B-cell ImmunologyImmunotoxicology and immune responses

Cited by 79

Emerging Immunotherapies for Parkinson Disease

Zella, S. M. A., Metzdorf, J., Ciftci, E., Ostendorf, F., Muhlack, S., Gold, R., & Tönges, L. (2019) · Neurology and Therapy

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 64

Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies

Schmidt, J., Elflein, K., Stienekemeier, M., Rodriguez-Palmero, M., Schneider, C., Toyka, K. V., Gold, R., & Hünig, T. (2003) · Journal of Neuroimmunology

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 59

Propionic acid and fasudil as treatment against rotenone toxicity in an in vitro model of Parkinson's disease

Ostendorf, F., Metzdorf, J., Gold, R., Haghikia, A., & Tönges, L. (2020) · Molecules

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 46

Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient

Wurm, H., Attfield, K., Iversen, A. K., Gold, R., Fugger, L., & Haghikia, A. (2020) · Multiple Sclerosis Journal

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 36

Author Correction: Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution

Masuda, T., Sankowski, R., Staszewski, O., Böttcher, C., Amann, L., Sagar, Scheiwe, C., Nessler, S., Kunz, P., van Loo, G., et al. (2019) · Nature

Neuroinflammation and Neurodegeneration MechanismsSingle-cell and spatial transcriptomics

Cited by 26